The DOI matches its Crossref record, with a small difference in title or year; 19 of the 19 references it cites were found in a registry or an index.
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
Open accessAbstract
The Rome IV Diagnostic Questionnaires were developed to screen for functional gastrointestinal disorders (FGIDs), serve as inclusion criteria in clinical trials, and support epidemiological surveys. Separate questionnaires were developed for adults, children/adolescents, and infants/toddlers. For the adult questionnaire, we first surveyed 1,162 adults without gastrointestinal disorders, and recommended the 90 th percentile symptom frequency as the threshold for defining what is abnormal. Diagnostic questions were formulated and verified with clinical experts using a recursive process. The diagnostic sensitivity of the questionnaire was tested in 843 patients from 9 gastroenterology clinics, with a focus on clinical diagnoses of irritable bowel syndrome (IBS), functional constipation (FC), and functional dyspepsia (FD). Sensitivity was 62.7% for IBS, 54.7% for FD, and 32.2% for FC. Specificity, assessed in a population sample of 5,931 adults, was 97.1% for IBS, 93.3% for FD, and 93.6% for FC. Excess overlap among IBS, FC, and FD was a major contributor to reduced diagnostic sensitivity, and when overlap of IBS with FC was permitted, sensitivity for FC diagnosis increased to 73.2%. All questions were understandable to at least 90% of individuals, and Rome IV diagnoses were reproducible in ¾ of patients after one month. Validation of the pediatric questionnaires is ongoing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This feature makes the Rome IV criteria potentially more specific than Rome III.”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This change reflected the findings of a normative survey showing that adopting a higher threshold for the frequency of abdominal pain required to meet criteria for IBS would lead to fewer healthy people in the general population being misclassified as having IBS, 9 and therefore risk being 'medicalised', and having to take drugs for the condition.”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [9]
In the citing paper
“Our study should also not be extrapolated to the other EDS subtypes, such as vascular EDS, which have recognised and potentially catastrophic gastrointestinal complications. 14”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [14]
In the citing paper
“To overcome these issues, an international consortium published updated guidelines in 2017, whereby far more stringent criteria will hopefully improve the diagnostic specificity of hEDS and allow clear distinction from HSD. 14,15”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · PubMed · Cited by 7,011
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,415
ROME III: The Functional Gastrointestinal Disorders
Sheth, A. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31804bbe26 · Cited by 1,974
Ware, J., Kosinski, M., Dewey, J., Gandek, B., Kisinski, M., Ware, J. E., & Dewey, J. M. (2001) · Cited by 824
Predictive Value of The Rome Criteria for Diagnosing The Irritable Bowel Syndrome
Vanner, S., Depew, W. T., Paterson, W. G., DaCosta, L. R., Groll, A., Simon, J. B., & Djurfeldt, M. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01437.x · Cited by 262
Self-citationWong, R. K., Palsson, O. S., Turner, M. J., Levy, R. L., Feld, A. D., von Korff, M., & Whitehead, W. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.200 · Cited by 204
Self-citationHeidelbaugh, J. J., Stelwagon, M., Miller, S. A., Shea, E. P., & Chey, W. D. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.67 · Cited by 159
Self-citationFord, A., Talley, N., van Zanten, S. V., Vakil, N., Simel, D., & Moayyedi, P. (2008) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.300.15.1793 · Cited by 132
Helgeland, H., Flagstad, G., Grøtta, J., Vandvik, P. O., Kristensen, H., & Markestad, T. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31818de3ab · Cited by 119
Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome
WHITEHEAD, W. E., PALSSON, O. S., FELD, A. D., LEVY, R. L., VON KORFF, M., TURNER, M. J., & DROSSMAN, D. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02956.x · Cited by 118
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 719
Chen, J., Lan, H., Li, C., Xie, Y., Cheng, X., Xia, R., Ke, C., & Liang, X. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae118 · Cited by 13
Pasricha, P. J., McKnight, M., Villatoro, L. G., Barahona, G. A., Brinker, J., Hui, K. Y., Polydefkis, M. J., Burns, R., McMahan, Z. H., Gould, N. F., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002910 · Cited by 10
Murray, H. B., Guadagnoli, L. A., Vanzhula, I. A., Brown, T. A., Sperber, A. D., Palsson, O. S., Bangdiwala, S. I., Oudenhove, L. V., & Staller, K. D. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14877 · Cited by 10
Self-citationFibromyalgia severity and symptoms are associated with the disorders of gut–brain interaction
Erdrich, S., & Harnett, J. (2024) · European Journal of Pain · doi:10.1002/ejp.4766 · Cited by 13
Zacharakis, G., Al-Ghamdi, S. H., Alzahrani, J. M., Almasoud, A., Arahmane, O., AlShehri, A., Alharbi, M. H., Alsalmi, M. M., Alotibi, S. B., Algaradi, Y. A., et al. (2020) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2020.110 · Cited by 10
Petrik, M. L., Palmer, B. E., Khoruts, A., & Vaughn, B. P. (2021) · Crohn's & Colitis 360 · doi:10.1093/crocol/otab061 · Cited by 12
Storr, M., Weigmann, H., Landes, S., & Michel, M. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216361 · Cited by 10
Chuah, K. H., Black, C. J., Tee, V., Lim, S., Hian, W. X., Sahran, N., Lee, Y. Y., Mahadeva, S., & Ford, A. C. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17567 · Cited by 11
Yoshioka, T., Takeshita, E., Sakata, Y., Hara, M., Akutagawa, K., Sakata, N., Endo, H., Ohyama, T., Matsunaga, K., Tanaka, Y., et al. (2017) · Esophagus · doi:10.1007/s10388-017-0573-9 · Cited by 10
Pazhouh, H. K., Hosseini, S. M. A.-R., Taghipour, A., Hamedi, S., & Noras, M. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-020-3267-4 · Cited by 11
“gut-brain microbiota was considered which has been introduced in recent years.((19,20)) The combined drug was found to have synergistic effects on the brain and digestion system.”
Shin, A., Xu, H., & Imperiale, T. F. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.08.005 · Cited by 10
Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome
Goodoory, V. C., Ng, C. E., Black, C. J., & Ford, A. C. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14483 · Cited by 9
Valero, M., Vélez, G. K. B., Oleas, R., Puga‐Tejada, M., Soria-Alcívar, M., Alvarado, H., Baquerizo‐Burgos, J., Pitanga‐Lukashok, H., & Robles‐Medranda, C. (2018) · Clinical Endoscopy · doi:10.5946/ce.2018.055 · Cited by 10
“Valero M et al. Capsule Endoscopy in Refractory IBS D-IBS, diarrhea-predominant irritable bowel syndrome. patients.8-11 On the other hand, there are some suggestions that organic gastrointestinal disorders (inflammatory bowel disease, colorectal cancer, or infectious diarrhea) can be identified in subsets of patients…”
BackgroundMethodMulak, A., Freud, T., Waluga, M., Bangdiwala, S. I., Palsson, O. S., & Sperber, A. D. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14568 · Cited by 9
Self-citationRiggott, C., Fairbrass, K. M., Selinger, C. P., Gracie, D. J., & Ford, A. C. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad256 · Cited by 9
Budzinska, A., Teysseire, F., Flad, E., Dupont, P. J., Wölnerhanssen, B. K., Meyer‐Gerspach, A. C., Oudenhove, L. V., & Weltens, N. (2024) · Appetite · doi:10.1016/j.appet.2024.107422 · Cited by 10
Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity
Wang, J., He, J., Liu, D., Zhang, T., Wu, Y., & Xie, M. (2024) · Microbiology and Immunology · doi:10.1111/1348-0421.13187 · Cited by 10
“According to the Rome IV criteria, the diagnosis of FC mainly relies on the patient's symptoms, including the sensation of difficulty or incomplete emptying of the bowels, and a decrease in the frequency of defecation [2 – 4].”
Pellegrino, R., & Gravina, A. G. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i8.101357 · Cited by 10
“ROME IV has produced a comprehensive questionnaire rich in questions designed to provide diagnostic insights based on the available criteria for functional gastrointestinal disorders[53].”
Palsson, O. S., Drossman, D. A., Jan, T., Nevé, B. L., Quinquis, L., Hassouna, R., Ruddy, J., Schmulson, M. J., Morris, C. B., Bangdiwala, S. I., et al. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70076 · Cited by 9
Self-citationDevelopment and Validation of a Bowel Diary for Fecal Incontinence: Comparison With a Questionnaire
Butt, M. F., Rao, S. S. C., Whitehead, W. E., Twist, S., Lowry, A. C., Wu, J. M., Bailey, K. R., & Bharucha, A. E. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70080 · Cited by 9
“The optimum number of response options in questionnaires is between four and seven [40], whereas the Rome IV questionnaire, which has 11 response options ranging from 0% to 100% in 10% increments for all bowel symptoms, might be considered excessive [41].”
Self-citationLorraine-Francis, H., Newberry, E., & Aziz, I. (2022) · Frontline Gastroenterology · doi:10.1136/flgastro-2022-102268 · Cited by 9
Diagnosis of Irritable Bowel Syndrome: Primary Care Physicians Compared with Gastroenterologists
Pareki, G., Wozniak, A. W., & Abegunde, A. T. (2023) · Clinical Medicine & Research · doi:10.3121/cmr.2023.1817 · Cited by 10
“15 In that validation study, Palsson et al noted that substantial overlap between patients with IBS, functional diarrhea, and functional constipation decreases the sensitivity of the Rome IV criteria as a diagnostic tool.”
BackgroundResultSilvernale, C. J., Garcia‐Fischer, I., & Staller, K. D. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08201-y · Cited by 9
Roth, B., & Ohlsson, B. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03373-x · Cited by 10
Acute colonic pseudo-obstruction after cesarean section and gastrointestinal symptoms⋆
Christensen, K., Ostersen, L. H., Glavind, K., Krarup, A. L., & Kjærgaard, N. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.06.011 · Cited by 9
Whitaker, L. H. R., Doust, A. M., Stephen, J., Norrie, J. D., Cooper, K. G., DANIELS, J. P., Hummelshøj, L., Cox, E., Beatty, L., CHIEN, P. F. W., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00740-9 · Cited by 9
“ Endometriosis Health Profile-30 (EHP-30) (10) Rome IV Criteria (11) Pelvic Pain and Urgency/Frequency Patient (PUF) Symptom Scale (12) painDETECTTM (13) Brief Fatigue Inventory (BFI) (14) Pain Catastrophising Questionnaire (PCQ) (15)”
BackgroundManagement of irritable bowel syndrome with diarrhea: focus on eluxadoline
Jones, J. R. A., Lembo, A. J., Heidelbaugh, J. J., Kuritzky, L., & Lacy, B. E. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1888705 · Cited by 11
Self-citationFairbrass, K. M., Selinger, C. P., Gracie, D. J., & Ford, A. C. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14256 · Cited by 9
The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
Morales, P. S., Wijeyesekera, A., Robertson, M. D., Jackson, P. P. J., & Gibson, G. R. (2022) · Microorganisms · doi:10.3390/microorganisms10122338 · Cited by 9
Abdominal symptoms during Sjogren’s syndrome: a pilot study
Parreau, S., Jacques, J., Dumonteil, S., Palat, S., Geyl, S., Gondran, G., Bézanahary, H., Liozon, E., Azaïs, J., Colombie, S., et al. (2021) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-021-00164-w · Cited by 9
Taghvaeinia, A., Karami, M., & Azizi, A. (2024) · Psychiatric Quarterly · doi:10.1007/s11126-023-10058-3 · Cited by 17
Kiattiweerasak, A., Bongkotvirawan, P., Aumpan, N., Yamaoka, Y., Miftahussurur, M., & Vilaichone, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291926 · Cited by 8
Katsumata, R., Hosokawa, T., & Kamada, T. (2023) · Cureus · doi:10.7759/cureus.49877 · Cited by 9
Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective
Hidayat, A. A., Waskito, L. A., Sugihartono, T., Aftab, H., Rezkitha, Y. A. A., Vilaichone, R., & Miftahussurur, M. (2024) · Intestinal Research · doi:10.5217/ir.2023.00199 · Cited by 8
“53,74 Therefore, it is imperative to conduct studies on the translation and validation of diagnostic questionnaires into the languages used in each country.”
BackgroundIrritable Bowel Syndrome in medical students at a Peruvian university: a cross-sectional study
Quiroga-Castañeda, P. P., Berrios-Villegas, I., Valladares-Garrido, D., Vera-Ponce, V. J., Zila-Velasque, J. P., Pereira-Victorio, C. J., & Valladares-Garrido, M. J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1341809 · Cited by 8
Olsen, B. C., Opheim, R., Kristensen, V. A., Høivik, M. L., Lund, C., Aabrekk, T. B., Johansen, I., Holten, K. I. A., Strande, V., Glad, I. F., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf047 · Cited by 8
Almario, C. V., Choi, S. Y., Chey, W. D., & Spiegel, B. M. R. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70020 · Cited by 8
Self-citationWierzbicka, A., Khaidakov, B., Zakerska‐Banaszak, O., Andrzejewska, P., Baturo, A., Kowalczyk, P. K., Lemke, K., Dobrowolska, A., Skrzypczak-Zielińska, M., & Mańkowska‐Wierzbicka, D. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1603011 · Cited by 11
Exploring new subgroups for irritable bowel syndrome using a machine learning algorithm
Mousavi, E., Keshteli, A. H., Sehhati, M., Vaez, A., & Adibi, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-45605-2 · Cited by 10
Zeevenhooven, J., Zeevenhooven, L., Biesbroek, A., Schappin, R., Vlieger, A. M., van Sleuwen, B. E., L’Hoir, M. P., & Benninga, M. A. (2024) · Acta Paediatrica · doi:10.1111/apa.17215 · Cited by 8
Robles‐Medranda, C., Oleas, R., Valero, M., Puga‐Tejada, M., Soria-Alcívar, M., Ospina, J., Alvarado‐Escobar, H., Muñoz‐Jurado, G., Baquerizo‐Burgos, J., & Pitanga‐Lukashok, H. (2020) · Endoscopy International Open · doi:10.1055/a-1119-6327 · Cited by 8
Schneider, É., Sabaté, J., Bouchoucha, M. L., Herçberg, S., Touvier, M., Benamouzig, R., Julia, C., & Buscail, C. (2021) · Nutrients · doi:10.3390/nu13124513 · Cited by 8
How much bloating in the irritable bowel syndrome?
Pop, L. L., Muresan, I. A. P., & Dumitrascu, D. L. (2018) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2018-0017 · Cited by 8
Yan, X.-X., Zhang, Y., Zhang, Y., Yang, Y., & Wu, D. (2024) · Chinese Medical Sciences Journal · doi:10.24920/004307 · Cited by 7
Self-citationBrick, C. R., Su, H. Y., Taylor, K. M., & Burgell, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164759 · Cited by 7
Jones, M., Holtmann, G., Tack, J. F., Carbone, F., Chey, W. D., Koloski, N. A., Shah, A., Bangdiwala, S. I., Sperber, A. D., Palsson, O. S., et al. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14940 · Cited by 7
Self-citationİnal, B., Yan, Y., Aziz, A., & Rao, S. S. C. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003532 · Cited by 9
Self-citationCaldart, F., Gabriel, C., Vauquelin, B., Rivière, P., Berger, A., & Zerbib, F. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003542 · Cited by 9
Implications of Shame for Patient-Reported Outcomes in Bowel Disorders of Gut-Brain Interaction
Trindade, I. A., Blomsten, A., Nybacka, S., Colomier, E., Sandberg, R., Frändemark, Å., Törnblom, H., & Simrén, M. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.06.030 · Cited by 9
Marasco, G., Schmulson, M. J., Ghoshal, U. C., Khatun, R., Bangdiwala, S. I., Cremon, C., Palsson, O. S., Sperber, A. D., & Barbara, G. (2026) · Gut · doi:10.1136/gutjnl-2025-336509 · Cited by 12
“22 DGBI diagnoses were assigned according to Rome IV criteria, based on responses to the Rome IV Diagnostic Questionnaire.”
Self-citationMehta, V. K., Mehta, A., Patel, S. B., Irastorza, L. E., Rizvi, S. A., Abomoelak, B., Mehta, N., & Mehta, D. I. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.646686 · Cited by 8
“FAPDs often overlap resulting in low sensitivity for questionnaire and classification (5).”
BackgroundBoks, M., Lilja, M., Widerström, M., Karling, P., Lindam, A. P., & Sjöström, M. (2023) · Parasitology Research · doi:10.1007/s00436-023-07866-8 · Cited by 7
Current Management of Chronic Constipation in Japan
Masaoka, T. (2023) · The Keio Journal of Medicine · doi:10.2302/kjm.2022-0036-ir · Cited by 7
Lee, A., Kim, H.-K., & Kim, H. (2024) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000798 · Cited by 7
Khalil, M., Abdallah, H., Calasso, M. P., Khalil, N., Daher, A., Missaoui, J., Diab, F., Zeaiter, L. Z., Vergani, L., Ciaula, A. D., et al. (2024) · Plants · doi:10.3390/plants13233340 · Cited by 7
Krynicka, P., Kaczmarczyk, M., Skonieczna‐Żydecka, K., Cembrowska-Lech, D., Podsiadło, K., Dąbkowski, K., Gaweł, K., Botke, N., Zawada, I., Ławniczak, M., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-024-03580-6 · Cited by 7
“The latter one is a standardized and validated measurement tool minimizing any bias in data collection and measurement [15].”
Houghton, L. A., Gao, S., Gilbert, S. A., Coffin, B., Simrén, M., Gale, J. D., & the A4451007 study investigators (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18487 · Cited by 7
Skonieczna‐Żydecka, K., Stachowska, E., Maciejewska, D., Ryterská, K., Palma, J., Czerwińska-Rogowska, M., Kaczmarczyk, M., Gudan, A., Mruk, H., Świniarska, B., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102256 · Cited by 7
“Nevertheless, studies evaluating the worldwide prevalence of FGID sufferers using most recent ROME IV criteria, report the drop down of IBS to 5–6%.”
BackgroundInfluentialKrammer, H., Storr, M., Madisch, A., & Riffel, J. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1340-0204 · Cited by 7
Mokha, J. S., Hyams, J. S., Glidden, N. C., Balarezo, F., & Young, E. E. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14185 · Cited by 7
Making a Confident Diagnosis of Irritable Bowel Syndrome
Goldstein, R. S., & Cash, B. D. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.004 · Cited by 7
Lucente, G., Corral, J., Rodríguez‐Esparragoza, L., Castañer, S., Ortiz, H., Piqueras, A., Broto, J., Hernández‐Pérez, M., Domènech, S., Martínez‐Piñeiro, A., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.755432 · Cited by 7
Kim, O., Cha, C., Jeong, H., Cho, M., & Kim, B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312324 · Cited by 7
Frequency and severity of irritable bowel syndrome in cigarette smokers, Turkey 2019
Başpınar, M. M., & Basat, O. (2022) · Tobacco Induced Diseases · doi:10.18332/tid/145925 · Cited by 7
Roth, B., Myllyvainio, J., D’Amato, M., Larsson, E., & Ohlsson, B. (2022) · Nutrients · doi:10.3390/nu14091688 · Cited by 7
Zhao, J., Xia, L. I., Zheng, H., Kun, Y. E., Wang, X., Xuefei, W., Runquan, S., & Zhigang, L. I. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20230105.002 · Cited by 8
Sehgal, K., Yadav, D., Saha, S., Mara, K. C., Grover, M., & Khanna, S. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.11.295 · Cited by 7
Advancements in drug development for diarrhea-predominant irritable bowel syndrome
Dothel, G., Barbaro, M. R., Raschi, E., Barbara, G., & Ponti, F. D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442434 · Cited by 7
Dynamic MRI of the pelvic floor: comparison of performance in supine vs left lateral body position
Schawkat, K., Pfister, B., Parker, H. L., Heinrich, H. S., Barth, B. K., Weishaupt, D., Fox, M. R., & Reiner, C. S. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180393 · Cited by 7
Papaefthymiou, A., Doulberis, M., Kountouras, J., Kolokytha, C., Galanopoulos, M., Liatsos, C. N., Kyriakos, N., Giakoumis, M., Papadomichelakis, M., Pοlyzos, S. A., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001439 · Cited by 7
Mosińska, P., Szczepaniak, A., Wojciechowicz, T., Skrzypski, M., Nowak, K. W., & Fichna, J. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02094-2 · Cited by 7
Osadchuk, M. A., Svistunov, A. А., Kireeva, N. V., & Osadchuk, M. M. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.02.000458 · Cited by 7
Incidence of Cancer in Patients with Irritable Bowl Syndrome
Loosen, S. H., Jördens, M. S., Luedde, M., Modest, D. P., Labuhn, S., Luedde, T., Kostev, K., & Roderburg, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245911 · Cited by 7
Silviera, M. L., & Keller, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-40232-3.00150-3 · Cited by 7
The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose
Shin, A., & Chang, L. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.032 · Cited by 7
Self-citationSeo, S., Wells, C. I., Dickson, T., Rowbotham, D., Gharibans, A., Calder, S., Bissett, I., O'Grady, G., & Erickson, J. (2023) · Scientific Reports · doi:10.1038/s41598-024-54429-7 · Cited by 4
“…or comorbidities that affect bowel motility/function (Parkinson’s disease, thyroid function diseases, and diabetes mellitus), or if they had a regular prescription for agents affecting bowel function (including, but not exclusive to, loperamide, prokinetics, metformin, laxatives, and opioids).”
BackgroundLipták, P., Ďuríček, M., Schnierer, M., Žiačiková, I., Rosoľanka, R., Baranovičová, E., Šturdík, I., Jackuliak, P., Veselíny, E., Varady, A., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002793 · Cited by 7
Konings, B., Balsiger, L. M., Hreinsson, J. P., Simrén, M., Bangdiwala, S. I., Sperber, A. D., Palsson, O. S., Törnblom, H., & Tack, J. F. (2025) · Gut · doi:10.1136/gutjnl-2024-334531 · Cited by 9
“The effect was moderate for most symptoms and large for the frequency of faecal urgency (online supplemental eTable 20).”
Self-citationAlmario, C. V., Eberlein, S. A., Khalil, C., & Spiegel, B. M. R. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14145 · Cited by 6
Self-citationSun, G., Trzpis, M., Ding, H., Gao, X., Broens, P. M. A., & Zhang, W. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14633 · Cited by 6
Freijy, T. M., Cribb, L., Oliver, G., Metri, N., Opie, R., Jacka, F. N., Hawrelak, J. A., Rucklidge, J. J., Ng, C. H., & Sarris, J. J. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2425570 · Cited by 6
Differentiating Between Lactose Intolerance, Celiac Disease, and Irritable Bowel Syndrome-Diarrhea
Luthy, K. E., Larimer, S. M., & Freeborn, D. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2017.01.018 · Cited by 7
“1% specificity.(21) The IBSchek was approved by the United States Food and Drug Administration for use in 2015 and is an enzyme-linked immunoassay‒based serum test that is predictive of IBS-D based on the presence of 1 or 2 antibodies: anti‒cytolethal distending toxin B and anti-vinculin.”
BackgroundUnderstanding the Rome IV: Irritable Bowel Syndrome and Functional Diarrhea
Kim, H. J., Cha, R. R., & Kim, H. J. (2017) · Korean Journal of Medicine · doi:10.3904/kjm.2017.92.4.366 · Cited by 6
Roseira, J., Lopes, R., Silva, M. J., Vieira, A. M., Sampaio, M., & Calinas, F. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.7444/2020 · Cited by 6
Outbreak of Cryptosporidium hominis in northern Sweden: persisting symptoms in a 5-year follow-up
Sjöström, M., Arvidsson, M., Söderström, L., Lilja, M., Lindh, J. G., & Widerström, M. (2022) · Parasitology Research · doi:10.1007/s00436-022-07524-5 · Cited by 7
Masticatory performance in patients with jaw muscle pain: A case–control study
Sayegh, S. A., Christidis, N., Kumar, A., Svensson, P. J., & Grigoriadis, A. (2022) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2022.963425 · Cited by 6
Purssell, H., Bennett, L., Street, O., Hanley, K. P., Hanley, N. A., Vasant, D. H., & Athwal, V. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-35774-5 · Cited by 6
Manipulation of the intestinal microbiome-a slow journey to primetime
Kriger-Sharabi, O., Malnick, S. D. H., & Fisher, D. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i21.4975 · Cited by 6
Irritable bowel syndrome (IBS) among Lebanese adults: unidentified IBS and associated factors
Yazbeck, G., Malaeb, D. N., Shaaban, H. S., Dine, A. S. E., Hallit, S. R., & Hallit, R. R. (2023) · BMC Public Health · doi:10.1186/s12889-023-16543-5 · Cited by 6
“Rome IV diagnostic questionnaire (for adults) This questionnaire was used for the diagnosis of irritable bowel syndrome [51].”
MethodDuncanson, K., Burrows, T. L., Keely, S., Potter, M. D. E., Das, G., Walker, M. M., & Talley, N. J. (2019) · Nutrients · doi:10.3390/nu11112590 · Cited by 6
“Self-report Minutes, prospective (5 min intervals vs. protocol) Y BSF: Bristol stool form, CHO: carbohydrate, FD: functional dyspepsia, FFQ: food frequency questionnaire, FGIDs: functional gastrointestinal disorders, FODMAP: fermentable oligosaccharides, disaccharides, monosaccharides and polyols, g/d: grams per day,…”
BackgroundResultInfluentialUsefulness of the hydrogen breath test in patients with functional dyspepsia
Chojnacki, C. J., Konrad, P., Błońska, A., Chojnacki, J., & Mędrek-Socha, M. (2020) · Gastroenterology Review · doi:10.5114/pg.2020.92690 · Cited by 6
Attari, A., Chey, W. D., Baker, J. R., & Ashton‐Miller, J. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228761 · Cited by 7
Self-citationTsai, Y.-J., Yang, Y.-W., & Lan, Y. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000462 · Cited by 6
Self-citationDisorders of Gut-brain Interaction on the US-Mexico Border
Bashashati, M., Schmulson, M. J., Sarosiek, I., Robles, A., Casner, N. A., Espino, K., Elhanafi, S. E., & Zuckerman, M. J. (2023) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001858 · Cited by 6
Editorial: new insights into the global prevalence of uninvestigated and functional dyspepsia
Potter, M. D. E., & Talley, N. J. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16059 · Cited by 6
Phan, T. N., Tran, Q. K., Truong, X. L., & Nguyen, T. H. T. (2025) · JGH Open · doi:10.1002/jgh3.70116 · Cited by 7
Snih, G. M. A., Bailey, K. R., Oblizajek, N. R., & Bharucha, A. E. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.05.005 · Cited by 5
Epidemiology of Meal‐Related Abdominal Discomfort or Pain in Irritable Bowel Syndrome
Cuffe, M. S., Goodoory, V. C., Ng, C. E., Black, C. J., & Ford, A. C. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70174 · Cited by 7
“We defined the presence of IBS using the Rome IV questionnaire [18], assigning presence of Rome IV-defined IBS according to the scoring algorithm proposed for its use [19].”
Patridge, E. V., Gorakshakar, A., Molusky, M. M., Ogundijo, O., Julian, C., Hu, L., Antoine, G., Vuyisich, M., Wohlman, R., & Banavar, G. S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04205-2 · Cited by 5
Youn, J. W., Joo, H., Kim, S., Oh, J., Yoo, H., Ko, J. S., Moon, J. S., Hahn, J. W., & Yon, D. K. (2026) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000001029 · Cited by 6
Metadata
- Authors
- Palsson, O. S., Whitehead, W. E., van Tilburg, M. A. L., Chang, L., Chey, W., Crowell, M. D., Keefer, L., Lembo, A. J., Parkman, H. P., Rao, S. S. C., Sperber, A., Spiegel, B., Tack, J., Vanner, S., Walker, L. S., Whorwell, P., & Yang, Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of California, Los Angeles (US)
- Michigan Medicine (US)
- Mayo Clinic in Arizona (US)
- Northwestern University (US)
- Harvard University (US)
- Temple University (US)
- Augusta University (US)
- KU Leuven (BE)
- Kingston General Hospital (CA)
- Vanderbilt University Medical Center (US)
- Chinese PLA General Hospital (CN)
- Corresponding author
- Palsson, Olafur S.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 150
- Issue
- 6
- Pages
- 1481-1491
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2344547018
- Cited by
- 719
- References
- 19
- Citations by year
- 2026: 79 · 2025: 99 · 2024: 92 · 2023: 88 · 2022: 70 · 2021: 92 · 2020: 76 · 2019: 41 · 2018: 46 · 2017: 24 · 2016: 10
- FWCI
- 43.99
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- Rome IV criteria, functional gastrointestinal disorders, irritable bowel syndrome, functional constipation, functional dyspepsia, sensitivity and specificity, diagnostic overlap, reproducibility, questionnaire validation, adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review